Navigation Links
'The Patient's Guide to Vasectomy Reversal' Now Available for Free for Increasing Number of Men Requesting the Procedure
Date:3/22/2010

NEW YORK, March 22 /PRNewswire/ -- Every year, roughly half a million men in the U.S. have a vasectomy to prevent pregnancy, but thousands later discover that they would actually like to father children, whether because they remarried or simply changed their minds.  The "Patient's Guide to Vasectomy Reversal" explains the procedure and answers the most frequently-asked questions, and is available for urologists through Sharpoint™ (Surgical Specialties Corporation), makers of microsurgical materials.  This booklet is also available to patients, free of charge, online at www.harryfisch.com or through the Male Reproductive Center at New York Presbyterian Hospital.

The booklet has been updated to reflect improvements in vasectomy reversal techniques and equipment that make the procedure faster and less expensive, which will allow many more men to fulfill their desire to father children.

"This technique is a refinement of the classic microsurgical operation that I've performed for many years," says Harry Fisch, M.D., Director of the Male Reproductive Center and a clinical professor of Urology and Reproductive Medicine at Weill Cornell Medical College/New York Presbyterian Hospital. "Instead of the usual large incision in the scrotum, we can now perform the procedure with a much smaller incision, using newer microsurgical techniques.  This new technique reduces the time required to reverse a vasectomy from about 4 hours to between 2 to 2-1/2 hours."

Because the operation, called a vasovasostomy, is faster and less disruptive to tissue, recovery is faster and patients experience less post-operative pain, Fisch says.  The time savings translate into lower costs for the patients.  

When performed by a skilled surgeon, the vasovasostomy procedure results in sperm returning to the semen in between 85% to 97% of men.  About 50% of couples subsequently achieve a pregnancy.  (Another form of vasectomy reversal, called a vasoepididymostomy, has lower success rates.)

"I would encourage any man interested in regaining his fertility after a vasectomy to learn more," Fisch says.

Dr. Harry Fisch, Clinical Professor of Urology and Reproductive Medicine, Weill-Cornell Medical College/New York Presbyterian Hospital, is a board-certified urologist and microsurgeon who is also one of the nation's leaders in the diagnosis and treatment of Men's health issues as well as sexuality and fertility problems in couples. Internationally renowned, he has pioneered microsurgical techniques for disorders associated with male infertility such as vasectomy reversal and repair of varicoceles. He is a frequent guest on the Doctor Oz Show and he has been frequently cited in a variety of publications, including USA Today, The New York Times, and The Washington Post and has appeared on television's 60 Minutes, 20/20, CNN and Today, among many others. He has been named to the "Best Doctors in America" and "New York Magazine Top Doctor" the past 9 years.

www.harryfisch.com

SOURCE Harry Fisch, M.D.

Back to top

RELATED LINKS
http://www.harryfisch.com

'/>"/>

SOURCE Harry Fisch, M.D.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Targeted therapy prolongs life in patients with HER2-positive breast cancer
2. Aspen Dental Opens 44 New Offices, Welcomes 340,000 New Patients in 2009
3. Blood Thinner Combos Risky for Heart Attack Patients
4. Patients with mild gallstone pancreatitis can undergo surgery sooner, shortening hospital stays
5. Brain Scans Suggest Some Vegetative Patients May Be Aware
6. Inflammation marker related to obesity is elevated in patients with pancreatic cancer
7. Adding Chemo to Tamoxifen Helps Some Breast Cancer Patients
8. Livonia Optometrist Offers New Technology - and New Hope - to Patients ... Free of Charge
9. HD For More Than Your TV – New Technologies Offer Patients High Definition Vision At Any Age
10. Molecule Discovery Might Help ALS Patients
11. Most Hospital Patients Dont Know What Meds Theyre Taking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... METTLER TOLEDO has ... personnel have a basic understanding of the techniques they use so they can ... help them reduce waste and rework to create a leaner overall lab experience. ...
(Date:2/9/2016)... ... ... i2i Systems, an early innovator and developer of population health management technology, ... report, Population Health Management 2015: How Far Can Your Vendor Take You? , ... The latest KLAS Report, leveraging over 200 user interviews, shines a light on ...
(Date:2/8/2016)... ... 08, 2016 , ... Brenntag Specialties, Inc.(BSI) , is ... & Beverage and Dietary Supplement market segments across the western ... geographies east of the Rocky Mountains since 2012. Consistent performance in business ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... L top-load case packer for pouches, bags, and flow wrapped products at WestPack ... co-packers and specialty product manufacturers step up to semi-automatic or fully-automatic case packing ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance agency ... Venice, FL area, has initiated a fundraiser for a two year old little ... days after Christmas. To support this beautiful child who is facing life’s journey ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... ORLANDO, Florida , February 9, 2016 /PRNewswire/ ... QIA) today announced a collaboration with 10x Genomics ... sequencing (NGS), single-cell biology and bioinformatics. --> ... announced a collaboration with 10x Genomics to develop ... single-cell biology and bioinformatics. --> QIAGEN ...
(Date:2/9/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a ... and heart failure, today announced that it intends to offer ... in an underwritten public offering.  The offering is subject to ... as to whether or when the offering may be completed, ... offering.   --> --> ...
Breaking Medicine Technology: